A team of researcher has engineered a ‘malaria-in-a-dish’ method that paves the way for better.
Indian-American researcher Siddhartha Mukherjee from Columbia University Medical Center (CUMC) has identified stem cells that.
Three-year outcomes from an ongoing clinical trial suggest that high-dose immunosuppressive therapy followed by
Groups at the Weizmann Institute of Science and Cambridge University have jointly managed the feat.
The technology for creating new tissues from stem cells has taken a giant leap forward..